News
-
Pulmatrix has presented data at the 11th US-Japan Symposium on Drug Delivery Systems in Hawaii that it says demonstrate the superiority of its iSPERSE inhalation platform over lactose formulations for combination dry powder inhalers. The… Read more . . .
-
Days after an FDA committee recommended approval of its lead product, Adasuve inhaled loxapine for the treatment of agitation in schizophrenia or bipolar disorder, Alexza Pharmaceuticals has announced that it is “exploring strategic options to… Read more . . .
-
Effective January 1 2012, the Seretide salmeterol xinafoate/fluticasone propionate Accuhaler 100 will cost £18 in the UK, a reduction of 42%. The price reduction is expected to save the National Health Service (NHS) £6.9 million… Read more . . .
-
ISTA Pharmaceuticals has rejected an unsolicited, non-binding proposal from Valeant Pharmaceuticals to acquire all of its outstanding shares on the grounds that the offer “was grossly inadequate.” ISTA’s board voted unanimously against the proposal. The… Read more . . .
-
In an article in the December 15 issue of the New England Journal of Medicine, regulators from the FDA’s Center for Drug Evaluation and Research (CDER), with Badhul Chowdhury, director of Division of Pulmonary, Allergy,… Read more . . .
-
According to MannKind Corporation, it has completely resolved arbitration initiated by a lawsuit filed by its former Senior Director – GCP – Regulatory Affairs, John Arditi, in 2010. Arditi, who had been responsible for MannKind’s… Read more . . .
-
US Patent No. 8,076,290 regarding stabilized formulations of parathyroid hormone (PTH) and PTH peptide analogs for various means of delivery, including intranasal delivery, has been awarded to Aegis Therapeutics. PTH and PTH peptide analogs such… Read more . . .
-
After meeting to discuss concerns about the safety of Alexza Pharmaceutical’s Adasuve Staccato loxapine, the FDA’s Psychopharmacologic Drugs Advisory Committee voted 9 to 8, with 1 abstention, to recommend approval for a single dose in… Read more . . .
-
An article published in the December 8, 2011 issue of the New England Journal of Medicine describes a proof of principle study in which an intranasal dry powder vaccine significantly reduced Norwalk virus gastroenteritis and… Read more . . .
-
DDL 22 finished up on Friday, December 9 with a series of talks related to physical and physicochemical properties of inhaled drugs, including several presentations by graduate students. Despite the fact that many delegates had… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.